Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

PoisoningProduct
Date
Apr 30, 2026
Company
Bayer HealthCare LLC, of Whippany, New Jersey
Product
Travel Size Afrin® Original Nasal Spray 6 mL Bottles
Reason
The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.
Hazard
Poisoning
Units
About 786,100
Remedy
Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.
Source
CPSC

How to identify the product

Official notice (CPSC)

Facts are taken from the official notice. If anything here differs from it, the official notice is correct.